6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
7m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
7m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
7m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
7m ago	When Blood Compatibility Becomes a Pregnancy Risk
8m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

4.34USD-0.03 -0.69%

Closed • Updated at 13:55 GMT+00:00

Market Cap$857.31M

P/E Ratio5.28

Volume41.8K

Beta0.70

RSI50.57

Gross Margin99.98%

Health TechnologyPharmaceuticals: Major

Arbutus Biopharma Corporation — investor relations, events, news, and company updates on 6ix.

Latest News

Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update

Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B

Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Community Chat

Ask AI